Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection

BACKGROUND: The novel coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has quickly spread worldwide since its outbreak in December 2019. One of the primary measures for controlling the spread of SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kesheng, Tong, Chongxiang, Ha, Xiaoqin, Zeng, Chaoning, Chen, Xia, Xu, Feifei, Yang, Jinhong, Du, Huifen, Chen, Yuxin, Cai, Jing, Yang, Zengwei, Jiang, Zhongyi, Chai, Dandan, Zhang, Xueliang, Li, Xun, Li, Junfeng, Yao, Liqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381135/
https://www.ncbi.nlm.nih.gov/pubmed/34425781
http://dx.doi.org/10.1186/s12879-021-06568-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381135/
https://www.ncbi.nlm.nih.gov/pubmed/34425781
http://dx.doi.org/10.1186/s12879-021-06568-9

Ejemplares similares